130 related articles for article (PubMed ID: 34494678)
1. Transcriptome analysis of human Leydig cell tumours reveals potential mechanisms underlying its development.
Kotula-Balak M; Duliban M; Gurgul A; Krakowska I; Grzmil P; Bilinska B; Wolski JK
Andrologia; 2021 Dec; 53(11):e14222. PubMed ID: 34494678
[TBL] [Abstract][Full Text] [Related]
2. Comparison of global gene expression profiles of microdissected human foetal Leydig cells with their normal and hyperplastic adult equivalents.
Lottrup G; Belling K; Leffers H; Nielsen JE; Dalgaard MD; Juul A; Skakkebæk NE; Brunak S; Rajpert-De Meyts E
Mol Hum Reprod; 2017 May; 23(5):339-354. PubMed ID: 28333300
[TBL] [Abstract][Full Text] [Related]
3. Switch of cadherin expression as a diagnostic tool for Leydig cell tumours.
Bremmer F; Schweyer S; Martin-Ortega M; Hammerlein B; Strauss A; Radzun HJ; Behnes CL
APMIS; 2013 Oct; 121(10):976-81. PubMed ID: 23398382
[TBL] [Abstract][Full Text] [Related]
4. Cellular proliferation and nuclear ploidy assessments augment established prognostic factors in predicting malignancy in testicular Leydig cell tumours.
McCluggage WG; Shanks JH; Arthur K; Banerjee SS
Histopathology; 1998 Oct; 33(4):361-8. PubMed ID: 9822927
[TBL] [Abstract][Full Text] [Related]
5. Abundance of DLK1, differential expression of CYP11B1, CYP21A2 and MC2R, and lack of INSL3 distinguish testicular adrenal rest tumours from Leydig cell tumours.
Lottrup G; Nielsen JE; Skakkebæk NE; Juul A; Rajpert-De Meyts E
Eur J Endocrinol; 2015 Apr; 172(4):491-9. PubMed ID: 25609776
[TBL] [Abstract][Full Text] [Related]
6. Leydig-cell tumour in children: variable clinical presentation, diagnostic features, follow-up and genetic analysis of four cases.
Petkovic V; Salemi S; Vassella E; Karamitopoulou-Diamantis E; Meinhardt UJ; Flück CE; Mullis PE
Horm Res; 2007; 67(2):89-95. PubMed ID: 17047343
[TBL] [Abstract][Full Text] [Related]
7. The natural history of Leydig cell testicular tumours: an analysis of the National Cancer Registry.
Nason GJ; Redmond EJ; Considine SW; Omer SI; Power D; Sweeney P
Ir J Med Sci; 2018 May; 187(2):323-326. PubMed ID: 28726031
[TBL] [Abstract][Full Text] [Related]
8. Origin and evolution of somatic cell testicular tumours in transgenic mice.
Quintana S; Venara M; Rey R; di Clemente N; Chemes HE
J Pathol; 2010 Aug; 221(4):443-51. PubMed ID: 20593483
[TBL] [Abstract][Full Text] [Related]
9. Testicular sex cord-stromal lesions: immunohistochemical analysis of cytokeratin, vimentin and steroidogenic enzymes.
Sasano H; Nakashima N; Matsuzaki O; Kato H; Aizawa S; Sasano N; Nagura H
Virchows Arch A Pathol Anat Histopathol; 1992; 421(2):163-9. PubMed ID: 1381130
[TBL] [Abstract][Full Text] [Related]
10. Expression patterns of DLK1 and INSL3 identify stages of Leydig cell differentiation during normal development and in testicular pathologies, including testicular cancer and Klinefelter syndrome.
Lottrup G; Nielsen JE; Maroun LL; Møller LM; Yassin M; Leffers H; Skakkebæk NE; Rajpert-De Meyts E
Hum Reprod; 2014 Aug; 29(8):1637-50. PubMed ID: 24908673
[TBL] [Abstract][Full Text] [Related]
11. Transcriptome modulation following administration of luteolin to bleomycin-etoposide-cisplatin chemotherapy on rat LC540 tumor Leydig cells.
Nguyen HT; Couture R; Touaibia M; Martin LJ
Andrologia; 2021 Mar; 53(2):e13960. PubMed ID: 33400304
[TBL] [Abstract][Full Text] [Related]
12. Testis sparing enucleation of a Leydig-cell tumour in a boy.
Merlini E; Seymandi PL; Betta PG; Bussi G
Pediatr Med Chir; 2003; 25(1):63-5. PubMed ID: 12920981
[TBL] [Abstract][Full Text] [Related]
13. Localization of S-100 protein in a Leydig and Sertoli cell tumour of testis.
McLaren K; Thomson D
Histopathology; 1989 Dec; 15(6):649-52. PubMed ID: 2606460
[TBL] [Abstract][Full Text] [Related]
14. Elevated levels of the steroidogenic factor 1 are associated with over-expression of CYP19 in an oestrogen-producing testicular Leydig cell tumour.
Straume AH; Løvås K; Miletic H; Gravdal K; Lønning PE; Knappskog S
Eur J Endocrinol; 2012 May; 166(5):941-9. PubMed ID: 22301800
[TBL] [Abstract][Full Text] [Related]
15. Use of antibodies against LH receptor, 3beta-hydroxysteroid dehydrogenase and vimentin to characterize different types of testicular tumour in dogs.
Peters MA; Teerds KJ; van der Gaag I; de Rooij DG; van Sluijs FJ
Reproduction; 2001 Feb; 121(2):287-96. PubMed ID: 11226053
[TBL] [Abstract][Full Text] [Related]
16. Immunohistological determination of oestrogen receptor, progesterone receptor, and intermediate filaments in Leydig cell tumours, Leydig cell hyperplasia, and normal Leydig cells of the human testis.
Düe W; Dieckmann KP; Loy V; Stein H
J Pathol; 1989 Mar; 157(3):225-34. PubMed ID: 2466972
[TBL] [Abstract][Full Text] [Related]
17. Leydig cell tumour: enucleation as a therapeutic choice in a case with atypical symptoms.
García M; Dargallo T; Palacios M; Carames J; Gómez J; Sacristán F; Vela D
Arch Esp Urol; 2012 Dec; 65(10):897-9. PubMed ID: 23269338
[TBL] [Abstract][Full Text] [Related]
18. Comparative transcriptome analysis reveals potential testosterone function-related regulatory genes/pathways of Leydig cells in immature and mature buffalo (Bubalus bubalis) testes.
Huang L; Xiao K; Zhang J; Zhang P; He W; Tang Y; Yang W; Huang X; Liu R; Liang X; Liu X; Fu Q; Lu Y; Zhang M
Gene; 2021 Nov; 802():145870. PubMed ID: 34363886
[TBL] [Abstract][Full Text] [Related]
19. Atypical presentation of Leydig cell tumour in three prepubertal patients: diagnosis, treatment and outcomes.
García González M; Casal-Beloy I; Somoza Argibay I; Dargallo Carbonell T
J Pediatr Endocrinol Metab; 2019 Apr; 32(4):369-374. PubMed ID: 30875329
[TBL] [Abstract][Full Text] [Related]
20. SRY-Positive 46, XX Testicular Disorder of Sexual Development With Leydig Cell Tumor.
Osaka A; Ide H; Matsuoka K; Iwahata T; Kobori Y; Ban S; Okada H; Saito K
Am J Mens Health; 2020; 14(5):1557988320970071. PubMed ID: 33131361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
